MacroGenics, Inc.
MGNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $72,839 | $22,241 | $13,192 | $17,730 |
| % Growth | 227.5% | 68.6% | -25.6% | – |
| Cost of Goods Sold | $13,378 | $8,906 | $5,400 | $5,490 |
| Gross Profit | $59,461 | $13,335 | $7,792 | $12,240 |
| % Margin | 81.6% | 60% | 59.1% | 69% |
| R&D Expenses | $32,709 | $40,791 | $39,698 | $38,890 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $9,905 | $9,302 | $10,718 | $27,810 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1,789 | $0 | $0 | -$1,623 |
| Operating Expenses | $40,825 | $50,093 | $50,416 | $65,077 |
| Operating Income | $18,636 | -$36,758 | -$42,624 | -$52,837 |
| % Margin | 25.6% | -165.3% | -323.1% | -298% |
| Other Income/Exp. Net | -$1,814 | $612 | $1,588 | $38,360 |
| Pre-Tax Income | $16,822 | -$36,146 | -$41,036 | -$14,477 |
| Tax Expense | $0 | $105 | $0 | $944 |
| Net Income | $16,822 | -$36,251 | -$41,036 | -$15,421 |
| % Margin | 23.1% | -163% | -311.1% | -87% |
| EPS | 0.27 | -0.57 | -0.65 | -0.25 |
| % Growth | 147.4% | 12.3% | -160% | – |
| EPS Diluted | 0.27 | -0.57 | -0.65 | -0.25 |
| Weighted Avg Shares Out | 63,233 | 63,136 | 62,965 | 62,621 |
| Weighted Avg Shares Out Dil | 63,284 | 63,136 | 62,965 | 62,621 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,528 | $1,414 | $1,679 | $2,086 |
| Interest Expense | $3,342 | $802 | $91 | $0 |
| Depreciation & Amortization | $1,789 | $1,907 | $1,771 | $2,053 |
| EBITDA | $21,953 | -$33,437 | -$39,174 | -$12,448 |
| % Margin | 30.1% | -150.3% | -297% | -70.2% |